Location: United States, Pennsylvania, Philadelphia
Employees: 11-50
Founded date: 1998
Investors 1
| Date | Name | Website |
| 14.05.2021 | EW Healthc... | ewhealthca... |
Mentions in press and media 12
| Date | Title | Description |
| 02.01.2014 | Safeguard CEO is new BFTP chairman [Startup Roundup] | WHO’S GETTING FUNDED? Osage University Partners participated in a $12 million Series B for Cambridge, Mass.-based storage performance acceleration software company Infinio, according to a release. Callowhill couponing app SnipSnap raised $4... |
| 06.12.2013 | Echo Therapeutics announces $15M offering | Echo Therapeutics (NSDQ:ECTE) is offering 3.2 million shares of its common stock in hopes of raising about $15 million. The Philadelphia-based company is raising the funds in order to cover the cost of the company’s Symphony continuous gluc... |
| 30.08.2013 | Echo Therapeutics shareholder proposes deal with China partner | Platinum-Montaur has threatened “further action” if the board does not respond to its proposal before 5pm on September 4. In the past year the company’s share price has fallen from a high of $18.51 to $2 since the start of the year from $13... |
| 02.08.2012 | Needle-free transdermal glucose monitor for critical care patients gets positive trial results | Although several glucose monitors have been on the market or are coming to market, Echo Therapeutics is keen to carve a niche for itself in the critical care area. But its CEO Patric Mooney also envisions the device as having potential for ... |
| 02.05.2012 | Painfree glucose monitoring system clinical trial nets positive results | Although there are several glucose monitoring systems on the market or being developed, Dr. Patrick Mooney’s Echo’s CEO and chairman said its device has a better error rate than its rivals and can give continuous readings. Mooney also sees ... |
| 06.01.2012 | Glucose monitor gives continuous reading with needle-free technology | Instead of using needles, like other glucose monitoring systems approved by the U.S. Food and Drug Administration, Echo uses a skin preparation system that measures the electrical conductivity of the skin region where the monitoring takes p... |
| 24.08.2011 | FDA fast-tracks Bayer’s promising prostate cancer treatment (Morning Read) | Emergency preparedness: There’s an app for that. Coincidentally in sync with yesterday’s earthquake, the Department of Health and Human Services has launched the “Lifeline Facebook App Challenge,” a contest to develop an app that would use ... |
| - | Echo Therapeutics shareholder proposes deal with China partner | It’s been a stormy week for Echo Therapeutics (NASDAQ: ECTE), a medical device company with a wireless, painfree continuous glucose monitoring system in the late stages of development. CEO Dr. Patrick Mooney took an immediate leave of absen... |
| - | FDA fast-tracks Bayer’s promising prostate cancer treatment (Morning Read) | Current medical news and unique business news for anyone who cares about healthcare. Bayer gets FDA boost. The FDA granted fast-track status to Bayer Healthcare Pharmaceuticals’ experimental prostate cancer treatment designed to release rad... |
| - | Needle-free transdermal glucose monitor for critical care patients gets positive trial results | A needle-free, transdermal glucose monitoring device for critical care patients has generated positive results in the second of two clinical trials. The study for Echo Therapeutics‘ (NASDAQ:ECTE) Symphony system was performed at Thomas Jeff... |
Show more